RingCentral (RNG) Competitors

Medpace (NASDAQ:MEDP) and RingCentral (NYSE:RNG) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends.

Does the media prefer MEDP or RNG?

In the previous week, Medpace had 6 more articles in the media than RingCentral. MarketBeat recorded 17 mentions for Medpace and 11 mentions for RingCentral. Medpace's average media sentiment score of 1.58 beat RingCentral's score of 0.83 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	16 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
RingCentral	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer MEDP or RNG?

Medpace currently has a consensus target price of $349.30, suggesting a potential upside of 18.41%. RingCentral has a consensus target price of $33.08, suggesting a potential upside of 23.12%. Given RingCentral's stronger consensus rating and higher possible upside, analysts plainly believe RingCentral is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
RingCentral	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31

Which has more risk & volatility, MEDP or RNG?

Medpace has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, RingCentral has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500.

Do institutionals & insiders believe in MEDP or RNG?

78.0% of Medpace shares are held by institutional investors. Comparatively, 98.6% of RingCentral shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 7.0% of RingCentral shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer MEDP or RNG?

RingCentral received 585 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 72.43% of users gave RingCentral an outperform vote while only 62.81% of users gave Medpace an outperform vote.

Company	Underperform	Outperform
Medpace	Outperform Votes 353 62.81%	Underperform Votes 209 37.19%
RingCentral	Outperform Votes 938 72.43%	Underperform Votes 357 27.57%

Which has better valuation and earnings, MEDP or RNG?

Medpace has higher earnings, but lower revenue than RingCentral. RingCentral is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.16B	3.93	$404.39M	$13.10	22.52
RingCentral	$2.43B	1.00	-$165.24M	-$0.44	-61.06

Is MEDP or RNG more profitable?

Medpace has a net margin of 19.17% compared to RingCentral's net margin of -2.43%. Medpace's return on equity of 51.48% beat RingCentral's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	19.17%	51.48%	20.47%
RingCentral	-2.43%	-12.34%	3.57%

Summary

Medpace beats RingCentral on 11 of the 18 factors compared between the two stocks.